Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Killer Cell Ig-Like Receptor-Dependent Signaling by Ig-Like Transcript 2 (ILT2/CD85j/LILRB1/LIR-1)
Sheryl Kirwan, Deborah N. Burshtyn
The Journal of Immunology (2005) Vol. 175, Iss. 8, pp. 5006-5015
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang, Pranav Oberoi, Sarah Oelsner, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 275
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger, Congcong Zhang, Patrick N. Harter, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 175
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Başar, Guohui Wang, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2133-2144
Open Access | Times Cited: 103
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
Xunlei Kang, Jaehyup Kim, Mi Deng, et al.
Cell Cycle (2015) Vol. 15, Iss. 1, pp. 25-40
Open Access | Times Cited: 174
Peptide antagonism as a mechanism for NK cell activation
Lena Fadda, Gwenoline Borhis, Parvin S. Ahmed, et al.
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 22, pp. 10160-10165
Open Access | Times Cited: 161
Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations
Kouyuki Hirayasu, Hisashi Arase
Journal of Human Genetics (2015) Vol. 60, Iss. 11, pp. 703-708
Open Access | Times Cited: 105
Ozone treatment ameliorates oil sands process water toxicity to the mammalian immune system
Erick García-García, Jun Ge, Ayoola Oladiran, et al.
Water Research (2011) Vol. 45, Iss. 18, pp. 5849-5857
Closed Access | Times Cited: 75
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Mi Deng, Heyu Chen, Xiaoye Liu, et al.
Antibody Therapeutics (2021) Vol. 4, Iss. 1, pp. 16-33
Open Access | Times Cited: 33
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma
Maja Strecker, Karolin Wlotzka, F Straßheimer, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 27
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004859-e004859
Open Access | Times Cited: 26
Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation
Marie-Luise Arnold, Alexander Kainz, Luis Hidalgo, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 9, pp. 2261-2273
Open Access | Times Cited: 41
Regulation of natural killer cell activity
Sheryl Kirwan, Deborah N. Burshtyn
Current Opinion in Immunology (2006) Vol. 19, Iss. 1, pp. 46-54
Closed Access | Times Cited: 58
Dengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK Cells
Oren Hershkovitz, Alon Zilka, Ahuva Bar-Ilan, et al.
Journal of Virology (2008) Vol. 82, Iss. 15, pp. 7666-7676
Open Access | Times Cited: 54
The Expanding Spectrum of Ligands for Leukocyte Ig-like Receptors
Deborah N. Burshtyn, Chris Morcos
The Journal of Immunology (2016) Vol. 196, Iss. 3, pp. 947-955
Open Access | Times Cited: 35
LILRB1 polymorphism and surface phenotypes of natural killer cells
Chelsea L. Davidson, Nicholas L. Li, Deborah N. Burshtyn
Human Immunology (2010) Vol. 71, Iss. 10, pp. 942-949
Closed Access | Times Cited: 37
Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94
Kuldeep Cheent, Khaleel Jamil, Sorcha Cassidy, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 42, pp. 16981-16986
Open Access | Times Cited: 33
The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis
Aleksandra Bylińska, Karolina Wilczyńska, Jacek Malejczyk, et al.
Molecular Genetics and Genomics (2017) Vol. 293, Iss. 3, pp. 601-613
Open Access | Times Cited: 31
LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions
Kang Yu, Chelsea L. Davidson, Agnieszka Wójtowicz, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 4, pp. 1523-1537
Open Access | Times Cited: 27
Vaccinia virus modulation of natural killer cell function by direct infection
Sheryl Kirwan, Deborah L. Merriam, Nicola Barsby, et al.
Virology (2006) Vol. 347, Iss. 1, pp. 75-87
Closed Access | Times Cited: 38
LFA-1 and CD2 Synergize for the Erk1/2 Activation in the Natural Killer (NK) Cell Immunological Synapse
Xiaodong Zheng, Yanyan Wang, Haiming Wei, et al.
Journal of Biological Chemistry (2009) Vol. 284, Iss. 32, pp. 21280-21287
Open Access | Times Cited: 32
Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
Silke Heidenreich, Christine zu Eulenburg, York Hildebrandt, et al.
Clinical and Developmental Immunology (2012) Vol. 2012, pp. 1-13
Open Access | Times Cited: 25
Cis association of leukocyte Ig‐like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18
Nicholas L. Li, Li Fu, Hannes Uchtenhagen, et al.
European Journal of Immunology (2013) Vol. 43, Iss. 4, pp. 1042-1052
Closed Access | Times Cited: 21
Immune Modulation by the Human Cytomegalovirus-Encoded Molecule UL18, a Mystery Yet to Be Solved
Claudia Wagner, Hans‐Gustaf Ljunggren, Adnane Achour
The Journal of Immunology (2008) Vol. 180, Iss. 1, pp. 19-24
Open Access | Times Cited: 25
NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
Julyun Oh, Charles Kirsh, Jing-Ping Hsin, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109913-109913
Open Access | Times Cited: 1
Clinical Production and Therapeutic Applications of Alloreactive Natural Killer Cells
David H. McKenna, Diane Kadidlo, Sarah Cooley, et al.
Methods in molecular biology (2012), pp. 491-507
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top